Tag: Ivonescimab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Ivonescimab

BMO says Keytruda 'still reigns' after ivonescimab survival data | Markets Insider

Added to Collection on: 2025-04-26 03:20:56

Tags for this article:

TipRanks
Angiogenesis inhibitors
Vascular endothelial growth factor
Society of Motor Manufacturers and Traders
Ivonescimab
BioNTech

Click the tags to see associated articles and topics

View Article Details
Wells says Summit, Akeso data 'not the bull case,' but not 'bear case either' | Markets Insider

Added to Collection on: 2025-04-26 01:34:13

Tags for this article:

Lung cancer
TipRanks
Tyrosine kinase receptors
Non-small-cell lung cancer
Anaplastic lymphoma kinase
Ivonescimab
Society of Motor Manufacturers and Traders
Summit Therapeutics

Click the tags to see associated articles and topics

View Article Details
Why Biotech Stars Summit Therapeutics and BioNTech Plunged, Even as This Chinese ... - Mitrade

Added to Collection on: 2025-04-25 22:18:48

Tags for this article:

BioNTech
Ivonescimab
Bispecific monoclonal antibody
MRNA vaccine
Pfizer-BioNTech COVID-19 vaccine
Summit Therapeutics

Click the tags to see associated articles and topics

View Article Details
Can China sustain a surge in oncology drug innovation? | PharmaVoice

Added to Collection on: 2025-07-02 13:34:16

Tags for this article:

Cancer immunotherapy
Pharmaceuticals policy
Antineoplastic drugs
Ivonescimab
Pharmaceutical industry in China
Merck & Co.
Pharmaceutical industry
Novartis
Pembrolizumab
Lansdell
Checkpoint inhibitor
China
Mark Lansdell

Click the tags to see associated articles and topics

View Article Details
Cue Biopharma, Inc. Reports New Complete Response and Confirms 50 ... - MarketScreener

Added to Collection on: 2025-07-16 20:54:01

Tags for this article:

Cancer immunotherapy
Antineoplastic drugs
Orphan drugs
Pembrolizumab
Head and neck cancer
Human papillomavirus infection
Squamous-cell carcinoma
Ivonescimab
Checkpoint inhibitor
Cue Biopharma Inc.

Click the tags to see associated articles and topics

View Article Details
Could bispecifics unseat Keytruda from its oncology throne? - PharmaVoice

Added to Collection on: 2025-07-28 16:36:25

Tags for this article:

Cancer immunotherapy
Antineoplastic drugs
Immune system
Ivonescimab
Pembrolizumab
Merck & Co.
Bristol-Myers Squibb
Programmed cell death protein 1
Pfizer
Checkpoint inhibitor
Ethan Smith

Click the tags to see associated articles and topics

View Article Details
The "disruptive therapy" for cancer, China's innovative drug's "DeepSeek moment"! The core keyword

Added to Collection on: 2025-08-31 12:22:29

Tags for this article:

Clusters of differentiation
Antineoplastic drugs
Orphan drugs
Cancer immunotherapy
Immune system
Programmed cell death protein 1
Pembrolizumab
PD-L1
Merck & Co.
Nivolumab
Bispecific monoclonal antibody
Ivonescimab
China

Click the tags to see associated articles and topics

View Article Details
Bispecific Antibodies in Oncology Market Forecast to Surge Over the Next Decade | DelveInsight

Added to Collection on: 2025-09-15 22:23:07

Tags for this article:

Immunology
Cancer immunotherapy
Monoclonal antibodies
Pharmaceutical companies
Bi-specific T-cell engager
Genmab
Bispecific monoclonal antibody
Ivonescimab
Targeted therapy
Antibody
Oncology
Novartis
Japan
United Kingdom
United States

Click the tags to see associated articles and topics

View Article Details
The Guardian view on Merck's exit: Britain's biopharma strategy stalls in the face of China's rise

Added to Collection on: 2025-09-15 19:15:56

Tags for this article:

Pharmacy
Cancer immunotherapy
Medical research
Immune system
Ivonescimab
Pembrolizumab
AstraZeneca
Pharmaceutical industry
Programmed cell death protein 1
GSK plc
Pfizer
Medication costs
Merck
United States
United Kingdom

Click the tags to see associated articles and topics

View Article Details
Book a Demo